Biomimetic nanomedicines for precise atherosclerosis theranostics.

Active targeting Atherosclerosis Biomimetic nanomedicines Diagnosis and treatment Drug delivery Nanotheranostics Passive targeting Plaques

Journal

Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 11 08 2022
revised: 13 10 2022
accepted: 28 10 2022
medline: 16 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: ppublish

Résumé

Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics.

Identifiants

pubmed: 37969739
doi: 10.1016/j.apsb.2022.11.014
pii: S2211-3835(22)00481-6
pmc: PMC10638499
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

4442-4460

Informations de copyright

© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

ACS Nano. 2015 Dec 22;9(12):11800-11
pubmed: 26516654
Nat Mater. 2021 Nov;20(11):1469-1479
pubmed: 34226688
Nat Commun. 2022 Jul 16;13(1):4137
pubmed: 35842431
Curr Opin Lipidol. 2010 Aug;21(4):312-8
pubmed: 20581677
Acta Pharm Sin B. 2021 Apr;11(4):941-960
pubmed: 33996408
ACS Nano. 2015;9(4):4435-46
pubmed: 25768046
Nat Rev Drug Discov. 2021 Feb;20(2):101-124
pubmed: 33277608
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):e36-48
pubmed: 22516067
EBioMedicine. 2018 Feb;28:225-233
pubmed: 29361501
Biomaterials. 2015;53:341-8
pubmed: 25890732
J Lipid Res. 2012 Mar;53(3):446-455
pubmed: 22190590
ACS Nano. 2016 Mar 22;10(3):3015-41
pubmed: 26889958
Signal Transduct Target Ther. 2021 Jun 7;6(1):225
pubmed: 34099630
Nat Med. 2011 Nov 07;17(11):1410-22
pubmed: 22064431
Nat Commun. 2020 Jan 10;11(1):214
pubmed: 31924781
Circulation. 2003 Dec 2;108(22):2737-42
pubmed: 14656908
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9445-50
pubmed: 23671083
Nat Rev Drug Discov. 2011 Oct 21;10(11):835-52
pubmed: 22015921
Bioconjug Chem. 2018 Aug 15;29(8):2526-2530
pubmed: 30059611
Adv Drug Deliv Rev. 2011 Mar 18;63(3):136-51
pubmed: 20441782
Sci Transl Med. 2020 Jul 22;12(553):
pubmed: 32718990
Nat Rev Drug Discov. 2011 Jun;10(6):417-27
pubmed: 21629292
JACC Cardiovasc Imaging. 2019 Oct;12(10):2015-2026
pubmed: 30343086
Nat Commun. 2014;5:3065
pubmed: 24445279
ACS Nano. 2015 Feb 24;9(2):1837-47
pubmed: 25619964
Cell. 2020 Apr 2;181(1):151-167
pubmed: 32243788
Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Nat Rev Cardiol. 2015 Apr;12(4):199-211
pubmed: 25666404
Nat Rev Cardiol. 2021 Sep;18(9):617-618
pubmed: 34262152
Theranostics. 2015 Apr 27;5(8):863-81
pubmed: 26000058
ACS Nano. 2019 Dec 24;13(12):13759-13774
pubmed: 31268670
Biomaterials. 2021 Jun;273:120810
pubmed: 33892346
Circulation. 2008 Jan 22;117(3):379-87
pubmed: 18158358
Nanoscale Res Lett. 2017 Dec;12(1):322
pubmed: 28472871
Circulation. 2003 Oct 7;108(14):1664-72
pubmed: 14530185
Circ Res. 2014 Jun 6;114(12):1852-66
pubmed: 24902970
Biomaterials. 2016 Sep;100:101-9
pubmed: 27254470
Circulation. 2006 Jun 13;113(23):2744-53
pubmed: 16754802
Nat Rev Mater. 2022;7(7):557-574
pubmed: 35251702
Trends Mol Med. 2014 May;20(5):271-81
pubmed: 24594264
J Control Release. 2019 Jun 10;303:263-273
pubmed: 30999008
Angew Chem Int Ed Engl. 2020 Mar 2;59(10):4068-4074
pubmed: 31854064
Nat Nanotechnol. 2020 Feb;15(2):154-161
pubmed: 31988506
J Control Release. 2014 Sep 28;190:531-41
pubmed: 24747161
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):148-156
pubmed: 26928656
ACS Nano. 2016 May 24;10(5):5280-92
pubmed: 27100066
Nat Rev Immunol. 2013 Oct;13(10):709-21
pubmed: 23995626
Nat Commun. 2018 Jul 11;9(1):2684
pubmed: 29992966
Adv Healthc Mater. 2020 Jul;9(14):e2000465
pubmed: 32543010
Nano Lett. 2018 Mar 14;18(3):1908-1915
pubmed: 29473753
Nanoscale. 2020 May 7;12(17):9541-9556
pubmed: 32314997
Adv Mater. 2018 Jun;30(23):e1706759
pubmed: 29582476
Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2520-2530
pubmed: 31597443
Biomaterials. 2021 Feb;269:120677
pubmed: 33503557
Circ Res. 2013 Jul 19;113(3):252-65
pubmed: 23748430
ACS Nano. 2018 Jan 23;12(1):109-116
pubmed: 29216423
Acta Pharm Sin B. 2022 Apr;12(4):2014-2028
pubmed: 35847489
Sci Rep. 2016 Mar 09;6:22910
pubmed: 26956647
Nat Rev Mater. 2021 Apr;6(4):351-370
pubmed: 34950512
Mol Pharm. 2010 Feb 1;7(1):3-11
pubmed: 19719324
J Control Release. 2008 Dec 18;132(3):171-83
pubmed: 18582981
Circ Res. 2012 Mar 30;110(7):927-37
pubmed: 22461363
Nat Rev Mater. 2022;7(10):796-813
pubmed: 35874960
Nat Rev Cardiol. 2017 Jan 17;14(2):71-72
pubmed: 28094270
J Control Release. 2019 Aug 28;308:71-85
pubmed: 31295543
Mol Pharm. 2013 Aug 5;10(8):3033-44
pubmed: 23819446
J Control Release. 2016 Aug 10;235:48-62
pubmed: 27235978
Trends Cell Biol. 2015 Nov;25(11):639-650
pubmed: 26437594
Circulation. 2001 Feb 27;103(8):1051-6
pubmed: 11222465
Nat Mater. 2016 Sep;15(9):1037-46
pubmed: 27213956
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55
pubmed: 17092599
ACS Nano. 2018 Sep 25;12(9):9568-9577
pubmed: 30130093
JACC Cardiovasc Imaging. 2013 Mar;6(3):373-84
pubmed: 23433925
Nat Rev Drug Discov. 2021 Aug;20(8):589-610
pubmed: 33976384
Sci Transl Med. 2015 Feb 18;7(275):275ra20
pubmed: 25695999
Nat Nanotechnol. 2008 Mar;3(3):145-50
pubmed: 18654486
Sci Transl Med. 2015 Jun 10;7(291):291ra94
pubmed: 26062846
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740
pubmed: 27791119
Mol Pharm. 2011 Jun 6;8(3):788-98
pubmed: 21473630
ACS Nano. 2018 Jul 24;12(7):6830-6842
pubmed: 29975503
Br J Pharmacol. 2021 Apr;178(7):1620-1638
pubmed: 33506494
Small. 2019 Apr;15(17):e1900132
pubmed: 30887709
J Nucl Med. 2017 Jul;58(7):1088-1093
pubmed: 28280218
ACS Nano. 2017 Feb 28;11(2):1816-1825
pubmed: 28121134
J Immunol. 2003 May 1;170(9):4793-801
pubmed: 12707361
Chem Soc Rev. 2016 Mar 7;45(5):1432-56
pubmed: 26771036
J Control Release. 2018 Jan 10;269:337-346
pubmed: 29175140
Science. 2012 Nov 16;338(6109):903-10
pubmed: 23161990
Sci Transl Med. 2019 Aug 21;11(506):
pubmed: 31434756
Sci Rep. 2015 Nov 30;5:17135
pubmed: 26616677
J Drug Target. 2014 Feb;22(2):138-45
pubmed: 24117054
Thromb Haemost. 2012 Dec;108(6):1208-19
pubmed: 23138460
Adv Mater. 2017 Feb;29(5):
pubmed: 27859662
Sci Transl Med. 2014 Jan 15;6(219):219ra7
pubmed: 24431111
ACS Nano. 2020 Mar 24;14(3):2585-2627
pubmed: 32031781
Atherosclerosis. 2015 Jul;241(1):100-10
pubmed: 25969893
Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2350-7
pubmed: 22879583
Adv Sci (Weinh). 2021 Feb 18;8(8):2004128
pubmed: 33898191
Adv Healthc Mater. 2017 Oct;6(20):
pubmed: 28730752
Nanomedicine. 2020 Oct;29:102274
pubmed: 32712174
Eur Heart J. 2018 Sep 14;39(35):3311-3313
pubmed: 30188979
Nat Rev Drug Discov. 2011 Jul 01;10(7):521-35
pubmed: 21720407
Adv Drug Deliv Rev. 2020;159:377-390
pubmed: 32791075
ACS Nano. 2018 Sep 25;12(9):9300-9308
pubmed: 30165015
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10648-10653
pubmed: 30275293
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1119-27
pubmed: 15802622
ACS Nano. 2020 Jun 23;14(6):6519-6531
pubmed: 32343121
Adv Mater. 2022 Jul;34(29):e2110660
pubmed: 35238081
Theranostics. 2018 Jun 12;8(13):3693-3706
pubmed: 30026877
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Adv Healthc Mater. 2020 Aug;9(16):e2000336
pubmed: 32597562
Circ Res. 2012 Mar 16;110(6):875-88
pubmed: 22427325
Adv Healthc Mater. 2019 Jun;8(11):e1900036
pubmed: 30945462
Sci Adv. 2020 May 27;6(22):eaba3167
pubmed: 32518825
Circ Res. 2020 Jan 3;126(1):25-37
pubmed: 31647755
Sci Adv. 2015 Apr;1(3):
pubmed: 26295063
ACS Nano. 2020 Feb 25;14(2):1856-1865
pubmed: 31909985
ACS Nano. 2019 May 28;13(5):5036-5048
pubmed: 30978282
Nat Biotechnol. 2006 Oct;24(10):1211-7
pubmed: 17033654
ACS Appl Mater Interfaces. 2021 Jul 7;13(26):30930-30940
pubmed: 34156244
Nat Rev Immunol. 2011 Apr;11(4):264-74
pubmed: 21436837
Int J Nanomedicine. 2020 Aug 14;15:6137-6152
pubmed: 32884268
J Control Release. 2019 May 28;302:105-115
pubmed: 30936020
ACS Nano. 2017 Jun 27;11(6):5785-5799
pubmed: 28463501
Nature. 2021 Apr;592(7855):524-533
pubmed: 33883728
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Nature. 2015 Oct 1;526(7571):118-21
pubmed: 26374997
Nat Rev Cardiol. 2019 Jan;16(1):21-32
pubmed: 30209355
Mol Pharm. 2019 Jul 1;16(7):3109-3120
pubmed: 31082253
Sci Adv. 2021 Apr 23;7(17):
pubmed: 33893103
ACS Appl Mater Interfaces. 2021 Jul 28;13(29):33862-33873
pubmed: 34256560
Nat Biomed Eng. 2018 May;2(5):279-292
pubmed: 30936448
J Control Release. 2020 Mar 10;319:77-86
pubmed: 31843641
Adv Mater. 2018 Nov;30(46):e1804023
pubmed: 30285289
Cancer Res. 2006 Jul 1;66(13):6732-40
pubmed: 16818648
Molecules. 2020 Apr 16;25(8):
pubmed: 32316285
Theranostics. 2021 Jan 1;11(6):2634-2654
pubmed: 33456564
Biomaterials. 2014 Sep;35(27):8002-14
pubmed: 24947229
Nat Rev Cardiol. 2010 Feb;7(2):77-86
pubmed: 20065951
Nat Rev Nephrol. 2017 Jun;13(6):368-380
pubmed: 28392564
Nat Commun. 2020 May 26;11(1):2622
pubmed: 32457361
J Hepatol. 2020 Jan;72(1):156-166
pubmed: 31568800
Biomater Sci. 2020 Jul 7;8(13):3640-3648
pubmed: 32458838
Acta Pharm Sin B. 2018 Jan;8(1):34-50
pubmed: 29872621
Curr Opin Lipidol. 2019 Oct;30(5):401-408
pubmed: 31361625
Sci Adv. 2020 Apr 29;6(18):eaaz6579
pubmed: 32494680
ACS Nano. 2014 Nov 25;8(11):11243-53
pubmed: 25318048
J Am Heart Assoc. 2012 Dec;1(6):e002568
pubmed: 23316318
Mol Pharm. 2019 Jul 1;16(7):3284-3291
pubmed: 31117743
Adv Mater. 2018 Jan;30(2):
pubmed: 29193346
Nanomedicine. 2021 Feb;32:102323
pubmed: 33186693
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):10980-5
pubmed: 21690347
Nanotheranostics. 2017 Apr 6;1(2):166-177
pubmed: 29071185
Nat Nanotechnol. 2014 Jun;9(6):481-7
pubmed: 24727688
Curr Atheroscler Rep. 2018 Nov 5;20(12):59
pubmed: 30397748
Acta Pharmacol Sin. 2021 Jan;42(1):10-17
pubmed: 32457416
ACS Nano. 2015 Sep 22;9(9):8885-97
pubmed: 26308181
Adv Drug Deliv Rev. 2018 Mar 15;128:84-100
pubmed: 29567396
Nano Lett. 2020 May 13;20(5):3079-3089
pubmed: 32348149
Nat Commun. 2018 Jan 15;9(1):231
pubmed: 29335450
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
J Control Release. 2018 Oct 28;288:136-147
pubmed: 30165141
Adv Mater. 2019 Jun;31(25):e1901513
pubmed: 31069885
J Control Release. 2021 Jan 10;329:445-453
pubmed: 33285103
Chem Sci. 2017 Oct 27;9(2):439-445
pubmed: 29629115
Biomaterials. 2020 Aug;250:119963
pubmed: 32334199
Nat Mater. 2020 May;19(5):566-575
pubmed: 31932672
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54
pubmed: 17875985
Small. 2020 Apr;16(16):e2000012
pubmed: 32239653
FASEB J. 2005 Mar;19(3):311-30
pubmed: 15746175
Circulation. 2002 Jun 4;105(22):2686-91
pubmed: 12045177
Adv Healthc Mater. 2015 Feb 18;4(3):367-76
pubmed: 25156590
J Extracell Vesicles. 2021 Sep;10(11):e12140
pubmed: 34520123
Photoacoustics. 2021 Mar 18;22:100262
pubmed: 33868920
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
Nat Rev Drug Discov. 2019 Jul;18(7):553-566
pubmed: 30967658
Nano Lett. 2017 Sep 13;17(9):5546-5554
pubmed: 28758755
Adv Sci (Weinh). 2019 Apr 24;6(12):1900172
pubmed: 31380165
Nat Immunol. 2011 Mar;12(3):204-12
pubmed: 21321594
N Engl J Med. 2018 Sep 06;379(10):958-966
pubmed: 30184457
Small. 2018 Jan;14(4):
pubmed: 29239134
J Control Release. 2014 Dec 10;195:72-85
pubmed: 25094032
Theranostics. 2021 Jan 1;11(1):164-180
pubmed: 33391468
Theranostics. 2016 Jan 01;6(2):272-86
pubmed: 26877785
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Biomaterials. 2020 Nov;260:120333
pubmed: 32853832
ACS Nano. 2020 Dec 22;14(12):17442-17457
pubmed: 33166111
Nat Commun. 2021 Jun 18;12(1):3754
pubmed: 34145241
JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34
pubmed: 19356492
Nat Rev Drug Discov. 2020 Apr;19(4):253-275
pubmed: 31969717
Nanomedicine. 2014 Jul;10(5):1003-12
pubmed: 24566276

Auteurs

Ying Tao (Y)

Department of Minimally Invasive Interventional Radiology, Key Laboratory of Molecular Target & Clinical Pharmacology, School of Biomedical Engineering & the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.

Xinmiao Lan (X)

School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.

Yang Zhang (Y)

Department of Cardiology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.

Chenxing Fu (C)

Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.

Lu Liu (L)

Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR 999077, China.

Feng Cao (F)

Department of Cardiology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.

Weisheng Guo (W)

Department of Minimally Invasive Interventional Radiology, Key Laboratory of Molecular Target & Clinical Pharmacology, School of Biomedical Engineering & the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.

Classifications MeSH